June 16 (Reuters) - Moderna appointed a new chief commercial officer and widened its president's role to oversee certain ...

U.S. Food and ‌Drug Administration staff reviewers said on Tuesday data demonstrating an immune response to Moderna's flu ...

Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA ...

Moderna (NASDAQ:MRNA) stock is jumping again. Shares are up 9% today, trading near $57 in the Tuesday afternoon session. That ...

The U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet ...

Dr. Stephen Hoge, President of Moderna, to Assume an Expanded Role With Operational Oversight of the Company's ...

Moderna is hoping to launch three new vaccines in the next couple of years – including a flu shot that will come in front of ...

Moderna (MRNA) stock gains as the FDA issues a "balanced" view on flu shot mRNA-1010 ahead of an AdCom meeting later this ...

Moderna Inc. (NASDAQ:MRNA) is one of the 10 Stocks Making Investors Richer. Moderna extended its winning streak to a fifth consecutive day on Wednesday, climbing 11.55 percent to end at $61.80 apiece, ...

CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its ...

Moderna is losing billions of dollars per year. The company has several promising new products that should be coming to the ...

CAMBRIDGE, MA / ACCESS Newswire / June 17, 2026 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its Investor Event - Science Day at 9:00am ET on Thursday, June 25, 2026.The event will ...